IPP Bureau
Elegen launches Enfina DNA enhancement for rapid synthesis of highly complex DNA
By IPP Bureau - March 21, 2024
Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days
Aurobindo Pharma receives USFDA approval for Mometasone Furoate Monohydrate nasal spray
By IPP Bureau - March 20, 2024
The approved product has an estimated market size of US$ 44.5 million for the twelve months ending January 2024
Apollo appoints Dr. Madhu Sasidhar as President & CEO, Hospitals Division
By IPP Bureau - March 20, 2024
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
AstraZeneca buys biopharmaceutical company Fusion
By IPP Bureau - March 20, 2024
To accelerate the development of next-generation radioconjugates to treat cancer
Lonza to buy US biologics site from Roche for US$ 1.2 billion
By IPP Bureau - March 20, 2024
Lonza plans to invest approximately CHF 500 million to upgrade the facility
Aster’s India and GCC business separation nearing completion
By IPP Bureau - March 20, 2024
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
Carbogen Amcis (Shanghai) completed ANVISA Audit
By IPP Bureau - March 19, 2024
A five-day inspection was concluded successfully with no critical and no major observations raised
Venus Remedies secures regulatory approvals for three key oncology drugs in Ukraine
By IPP Bureau - March 19, 2024
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Grace expands CDMO capacity by 25% of South Haven facility in Michigan
By IPP Bureau - March 19, 2024
Additional capacity broadens Grace’s fine chemical capabilities for API production
Dr. Reddy's Laboratories launches Versavo in the UK
By IPP Bureau - March 19, 2024
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
Sun Pharmaceuticals receives approval for Winlevi in Australia
By IPP Bureau - March 19, 2024
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Zydus receives USFDA approval for Finasteride and Tadalafil capsules
By IPP Bureau - March 18, 2024
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
AstraZeneca to acquire Amolyt Pharma
By IPP Bureau - March 18, 2024
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Lupin appoints Christoph Funke as Chief Technical Operations Officer
By IPP Bureau - March 18, 2024
Christoph Funke's extensive career includes leadership roles at organizations such as Fresenius Kabi and Strides Pharma Science
Eris Lifesciences buys India formulation business of Biocon Biologics for Rs. 1,242 Cr
By IPP Bureau - March 17, 2024
Both organisations enter into a long- term collaboration to expand patient access in India
